Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-25 07:31:36 ET
Novozymes A/S (NVZMY) Q4 2025 Earnings Call February 25, 2026 3:00 AM EST
Company Participants
Tobias Björklund - Head of Investor Relations
Ester Baiget - President & CEO
Rainer Lehmann - Executive VP & CFO
Henrik Nielsen - EVP of Human Health Biosolutions and Strategy & Integration
Claus Fuglsang - Chief Scientific Officer
Andrew Taylor - Executive Vice President of Food & Beverage Biosolutions
Tina Fanø - Executive Vice President of Planetary Health Biosolutions
...
Read the full article on Seeking Alpha
For further details see:
Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript
Novozymes A/S ADR
NASDAQ: NVZMY
NVZMY Trading
0.83% G/L:
$54.55 Last:
27,606 Volume:
$54.70 Open:
